Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis

Polypharmacy (intake of ≥5 drugs) is an important issue for patients with chronic diseases such as multiple sclerosis (MS). We aimed to assess the prevalence of polypharmacy with regard to the severity of anxiety/depression and to comorbidities. Therefore, 374 MS patients from two German neurologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldt, Julia, Frahm, Niklas, Hecker, Michael, Streckenbach, Barbara, Langhorst, Silvan Elias, Mashhadiakbar, Pegah, Burian, Katja, Meißner, Janina, Heidler, Felicita, Richter, Jörg, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456074/
https://www.ncbi.nlm.nih.gov/pubmed/37629420
http://dx.doi.org/10.3390/jcm12165379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456074/
https://www.ncbi.nlm.nih.gov/pubmed/37629420
http://dx.doi.org/10.3390/jcm12165379

Ejemplares similares